Sarda Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/11/2025 ,inter alia, to consider and approve unaudited financial results ....
Awaiting price reaction for this filing.
Sarda Proteins Ltd has informed BSE that its Board of Directors will meet on Wednesday, 26th November 2025. The key agenda item is to consider and approve the unaudited financial results for the quarter and half year ended 30th September 2025 (Q2 and H1 of FY26). The company has also noted that the trading window for insiders is closed from 1st October 2025 and will reopen 48 hours after the board meeting outcome is announced. This is a standard regulatory filing under SEBI LODR Regulation 29(1). No financial figures or business commentary are provided at this stage.
No direct impact on the stock from this filing itself. Investors should watch for the actual Q2/H1 results announcement on or after 26th November 2025, which may move the stock depending on the numbers reported.